Literature DB >> 3416180

Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease.

T H McNeill1, S A Brown, J A Rafols, I Shoulson.   

Abstract

Loss of dopaminergic neurons from the pars compacta of the substantia nigra is the pathological hallmark of Parkinson's disease (PD) and results in a partial deafferentation to the striatum. Since deafferentation is known to induce transynaptic atrophy of postsynaptic cells, we examined by Golgi impregnation the morphology of medium spiny I (MSI) striatal neurons, the principal target population for both nigrostriatal and corticostriatal fibers. Our quantitative data indicate that the dendritic arbor of MSI neurons in the putamen is significantly reduced in both length and number and MSI neurons are morphologically characterized by truncated dendrites with few dendritic spines and irregular, bulbous swellings. These data provide morphological evidence for the atrophy of striatal dendrites in PD and may explain, in part, the declining efficacy of chronic L-DOPA replacement therapy in advanced PD.

Entities:  

Mesh:

Year:  1988        PMID: 3416180     DOI: 10.1016/0006-8993(88)90124-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  79 in total

1.  Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.

Authors:  Bonnie G Garcia; M Diana Neely; Ariel Y Deutch
Journal:  Cereb Cortex       Date:  2010-01-29       Impact factor: 5.357

2.  Iron mediates neuritic tree collapse in mesencephalic neurons treated with 1-methyl-4-phenylpyridinium (MPP+).

Authors:  Francisco J Gómez; Pabla Aguirre; Christian Gonzalez-Billault; Marco T Núñez
Journal:  J Neural Transm (Vienna)       Date:  2010-10-02       Impact factor: 3.575

3.  Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons.

Authors:  M D Neely; D E Schmidt; A Y Deutch
Journal:  Neuroscience       Date:  2007-07-17       Impact factor: 3.590

4.  The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors.

Authors:  K E Soderstrom; G Meredith; T B Freeman; S O McGuire; T J Collier; C E Sortwell; Qun Wu; K Steece-Collier
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

5.  Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease.

Authors:  Giselle M Petzinger; Beth E Fisher; Sarah McEwen; Jeff A Beeler; John P Walsh; Michael W Jakowec
Journal:  Lancet Neurol       Date:  2013-07       Impact factor: 44.182

6.  Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway.

Authors:  C A Ingham; S H Hood; B van Maldegem; A Weenink; G W Arbuthnott
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

7.  Identification and validation of novel spinophilin-associated proteins in rodent striatum using an enhanced ex vivo shotgun proteomics approach.

Authors:  Anthony J Baucum; Nidhi Jalan-Sakrikar; Yuxia Jiao; Richard M Gustin; Leigh C Carmody; David L Tabb; Amy-Joan L Ham; Roger J Colbran
Journal:  Mol Cell Proteomics       Date:  2010-02-02       Impact factor: 5.911

Review 8.  Changes in the osteocyte lacunocanalicular network with aging.

Authors:  LeAnn M Tiede-Lewis; Sarah L Dallas
Journal:  Bone       Date:  2019-02-08       Impact factor: 4.398

9.  BDNF in the Aged Brain: Translational Implications for Parkinson's Disease.

Authors:  N M Mercado; T J Collier; C E Sortwell; K Steece-Collier
Journal:  Austin Neurol Neurosci       Date:  2017-09-19

Review 10.  The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.

Authors:  Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol       Date:  2010-06-20       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.